Not quite, primaus72, P2b was run against Lucentis monotherapy only. No Eylea arm included back then.
Instead, COAST is the very first time sozinibercept formaly is being tested against Eylea monotherapy
- Forums
- ASX - By Stock
- Ann: Security Class Reinstatement to Quotation- OPTOB
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Not quite, primaus72, P2b was run against Lucentis monotherapy...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable